PLATELET-TO-LYMPHOCYTE AND NEUTROPHIL-TO-LYMPHOCYTE RATIOS AND THEIR RELATION TO DISEASE ACTIVITY IN INFLAMMATORY BOWEL DISEASE
Nouh, H., Elhadidy, A., Mohamed, E., Hashish, F. (2024). PLATELET-TO-LYMPHOCYTE AND NEUTROPHIL-TO-LYMPHOCYTE RATIOS AND THEIR RELATION TO DISEASE ACTIVITY IN INFLAMMATORY BOWEL DISEASE. EKB Journal Management System, 6(3), 41-42. doi: 10.21608/alexpo.2024.311800.1915
Hanan Hosny Nouh; Abeer Shawky Elhadidy; Eman Ahmed Mohamed; Farah Mohammad Hashish. "PLATELET-TO-LYMPHOCYTE AND NEUTROPHIL-TO-LYMPHOCYTE RATIOS AND THEIR RELATION TO DISEASE ACTIVITY IN INFLAMMATORY BOWEL DISEASE". EKB Journal Management System, 6, 3, 2024, 41-42. doi: 10.21608/alexpo.2024.311800.1915
Nouh, H., Elhadidy, A., Mohamed, E., Hashish, F. (2024). 'PLATELET-TO-LYMPHOCYTE AND NEUTROPHIL-TO-LYMPHOCYTE RATIOS AND THEIR RELATION TO DISEASE ACTIVITY IN INFLAMMATORY BOWEL DISEASE', EKB Journal Management System, 6(3), pp. 41-42. doi: 10.21608/alexpo.2024.311800.1915
Nouh, H., Elhadidy, A., Mohamed, E., Hashish, F. PLATELET-TO-LYMPHOCYTE AND NEUTROPHIL-TO-LYMPHOCYTE RATIOS AND THEIR RELATION TO DISEASE ACTIVITY IN INFLAMMATORY BOWEL DISEASE. EKB Journal Management System, 2024; 6(3): 41-42. doi: 10.21608/alexpo.2024.311800.1915

PLATELET-TO-LYMPHOCYTE AND NEUTROPHIL-TO-LYMPHOCYTE RATIOS AND THEIR RELATION TO DISEASE ACTIVITY IN INFLAMMATORY BOWEL DISEASE

ALEXMED ePosters
Article 1, Volume 6, Issue 3, July 2024, Page 41-42  XML
Document Type: Preliminary preprint short reports of original research
DOI: 10.21608/alexpo.2024.311800.1915
View on SCiNiTO View on SCiNiTO
Authors
Hanan Hosny Nouh1; Abeer Shawky Elhadidy2; Eman Ahmed Mohamed3; Farah Mohammad Hashish email 1
1Department of Internal Medicine and Gastroenterology, Faculty of Medicine, Alexandria University
2Department of Clinical and Chemical Pathology, Faculty of Medicine, Alexandria University
3Department of Internal Medicine, Gastro-Enterology unit, Faculty of Medicine, Alexandria University
Abstract
• Inflammatory Bowel Disease (IBD) is a chronic disease characterized by remission and relapse of inflammation of the gastrointestinal mucosa.
• Its etiopathogenesis is not completely understood but several immunologic, genetic, and environmental factors may contribute to this disease. One of the hypotheses is dysregulated immune response to gut dysbiosis.
• IBD encompasses Ulcerative Colitis (UC) which causes diffusely inflamed mucosa limited to the colon, and Crohn’s disease (CD) which results in focal involvement of any site of the gastrointestinal tract, most commonly the terminal ileum and colon.
• Diagnosis depends on the integrated assessment of clinical presentation, laboratory investigations, imaging, endoscopy and histopathological examination. Ileocolonoscopy and biopsies are considered the gold standard of diagnosis; nevertheless, they are invasive, costly, and inconvenient for most patients.
• Studies aim to find other non-invasive methods that correlates with disease activity which are easily feasible like Platelet-To-Lymphocyte Ratio (PLR) and Neutrophil-To-Lymphocyte Ratio (NLR).
Keywords
Inflammatory Bowel Disease (IBD); Platelet-To-Lymphocyte Ratio (PLR); Neutrophil-To-Lymphocyte Ratio (NLR)
Supplementary Files
Statistics
Article View: 85